301277 Stock Overview
Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Newland Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.88 |
| 52 Week High | CN¥31.48 |
| 52 Week Low | CN¥13.02 |
| Beta | 0 |
| 1 Month Change | 9.05% |
| 3 Month Change | 27.68% |
| 1 Year Change | -10.58% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.08% |
Recent News & Updates
Shareholder Returns
| 301277 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 8.0% | 2.7% | 1.2% |
| 1Y | -10.6% | -10.9% | -12.6% |
Return vs Industry: 301277 matched the CN Pharmaceuticals industry which returned -10.9% over the past year.
Return vs Market: 301277 exceeded the CN Market which returned -12.6% over the past year.
Price Volatility
| 301277 volatility | |
|---|---|
| 301277 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 301277's share price has been volatile over the past 3 months.
Volatility Over Time: 301277's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,010 | Luwei Zhang | www.newlandpharma.com |
Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers intermediates, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd.
Newland Pharmaceutical Co., Ltd. Fundamentals Summary
| 301277 fundamental statistics | |
|---|---|
| Market cap | CN¥3.98b |
| Earnings (TTM) | CN¥168.18m |
| Revenue (TTM) | CN¥663.48m |
23.6x
P/E Ratio6.0x
P/S RatioIs 301277 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301277 income statement (TTM) | |
|---|---|
| Revenue | CN¥663.48m |
| Cost of Revenue | CN¥390.65m |
| Gross Profit | CN¥272.82m |
| Other Expenses | CN¥104.64m |
| Earnings | CN¥168.18m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 41.12% |
| Net Profit Margin | 25.35% |
| Debt/Equity Ratio | 0% |
How did 301277 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield48%
Payout RatioDoes 301277 pay a reliable dividends?
See 301277 dividend history and benchmarks| Newland Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | May 10 2024 |
| Dividend Pay Date | May 10 2024 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 5 days |
Does 301277 pay a reliable dividends?
See 301277 dividend history and benchmarks